BioReference Reports Purchase of Edge BioSystems' Service Business, No Terms Disclosed

BioReference Laboratories, Inc. (Nasdaq: BRLI ) announced today that it has entered into a definitive agreement for the acquisition of Edge BioSystems CLIA laboratory business and related assets ("Edge BioServ"), primarily a genetic sequencing service business located in Gaithersburg, MD. GeneDx, BRLI's wholly-owned clinical diagnostic sequencing laboratory, will acquire the Edge BioServ genetic sequencing services